EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

A Retrospective Cohort Study to Optimize Piperacillin/Tazobactam Dosing in Routine Intensive-Care Patients via a Newly Designed Clinical Pharmacy Service Including TDM- and Algorithm-Based Recommendations

Johanna Dicken, Daniel Dönisch, Jan Hensen, Olaf Zube, Thilo Bertsche iD

Pharmacy · 17.08.2026 · 14 (5) · 120

DOI: 10.3390/pharmacy14050120 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pharmacy, online erschienen am 17.08.2026. Verfasst von Johanna Dicken und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Bundeswehr Hospital Hamburg, 22049 Hamburg, Germany. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Access Publication Fund of Leipzig University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Therapeutic drug monitoring (TDM) for piperacillin/tazobactam has become established in intensive care. TDM should be used in a structured approach to optimize dosing. We evaluated a newly designed TDM- and algorithm-based clinical-pharmacy-service to determine whether it is appropriate for optimization.

Methods

We developed a clinical pharmacy service providing algorithmic recommendations for optimizing piperacillin/tazobactam dosing based on piperacillin TDM. After implementing the clinical pharmacy service, we evaluated the treatment of intensive-care patients with piperacillin/tazobactam in terms of achieving the minimum-inhibitory-concentration-(MIC)-related target concentration at the following four time points: t1, t2, t3, and t4 (1–4 working days after piperacillin/tazobactam therapy was started).

Results

A total of 132 patients (including 36% women), median age 78 years, received piperacillin/tazobactam therapy. Sepsis or septic shock was the most common indication (43%), while a pulmonary focus was most frequent (40%). From 132 patients (t1), 19% had “too low piperacillin concentrations”, 20% “appropriate concentrations”, and 61% “too high concentrations”. After recommendations were given (acceptance rate 100%) the corresponding numbers from 93 remaining patients (t2) were 16%, 35%, and 48%, from 49 patients (t3) 8%, 53%, and 39% and from 29 patients (t4) 38%, 45%, and 17%. In (t1), dose reduction was the main recommendation (49%). The number of patients with “appropriate concentrations” increased in one comparison (t1–t2: n.s.; t1–t3: p = 0.0013; t1–t4: n.s.; Bonferroni-corrected McNemar test), while “too high concentrations” decreased (t1–t2: p = 0.0080; t1–t3: p = 0.0056; t1–t4: p = 0.0095). “too low concentrations” were not influenced (t1–t2: n.s.; t1–t3: n.s.; t1–t4: n.s.).

Conclusions

Inappropriate piperacillin plasma concentrations were common. A TDM- and algorithm-based clinical-pharmacy-service especially decreased the number of overdosed patients in routine practice.

Schlagwörter

Stichwörter der Autor:innen

clinical-pharmacy-servicesdecision managementdrug dosage calculationshospital pharmacypharmacy managementpiperacillintherapeutic drug monitoring

Autor:innen und Institutionen

  • Pharmacy Department, Bundeswehr Hospital Hamburg, 22049 Hamburg, Germany.
  • Department of Anesthesia and Intensive-Care, Bundeswehr Hospital Hamburg, 22049 Hamburg, Germany.
  • Clinical Pharmacy Department, Institute of Pharmacy, Medical Faculty, Leipzig University, 04103 Leipzig, Germany.
  • Drug Safety Center, Medical Faculty, Leipzig University Hospital, Leipzig University, 04103 Leipzig, Germany.

ORCID-Profile: Thilo Bertsche

Förderung

  • Open Access Publication Fund of Leipzig University

Zitieren

APA

Dicken, J., Dönisch, D., Hensen, J., Zube, O., & Bertsche, T. (2026). A Retrospective Cohort Study to Optimize Piperacillin/Tazobactam Dosing in Routine Intensive-Care Patients via a Newly Designed Clinical Pharmacy Service Including TDM- and Algorithm-Based Recommendations. Pharmacy, 14(5), 120. https://doi.org/10.3390/pharmacy14050120

Vancouver

Dicken J, Dönisch D, Hensen J, Zube O, Bertsche T. A Retrospective Cohort Study to Optimize Piperacillin/Tazobactam Dosing in Routine Intensive-Care Patients via a Newly Designed Clinical Pharmacy Service Including TDM- and Algorithm-Based Recommendations. Pharmacy. 2026;14(5):120. doi:10.3390/pharmacy14050120

BibTeX
@article{Dicken2026,
  author = {Dicken, Johanna and Dönisch, Daniel and Hensen, Jan and Zube, Olaf and Bertsche, Thilo},
  title = {A Retrospective Cohort Study to Optimize Piperacillin/Tazobactam Dosing in Routine Intensive-Care Patients via a Newly Designed Clinical Pharmacy Service Including TDM- and Algorithm-Based Recommendations},
  journal = {Pharmacy},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {120},
  doi = {10.3390/pharmacy14050120}
}
Kostenlos starten →